(Translated by https://www.hiragana.jp/)
MERS: Difference between revisions - Wikipedia

MERS: Difference between revisions

Content deleted Content added
Citation bot (talk | contribs)
Alter: title, template type. Add: chapter. Removed parameters. | Use this bot. Report bugs. | Suggested by Eastmain | Category:Atypical pneumonias | #UCB_Category 1/19
m Normalized list spaces and updated date format specifier.
 
(9 intermediate revisions by 7 users not shown)
Line 1:
{{Short description|Viral respiratory infection}}
{{cs1 config|name-list-style=vanc|display-authors=3}}
{{other uses|Mers (disambiguation)}}
{{About|the disease|the virus that causes it|Middle East respiratory syndrome–related coronavirus}}
{{Use dmy dates|date=JanuaryApril 20202024}}
{{Infobox medical condition (new)
| name = Middle East respiratory syndrome<br />(MERS)
| synonyms = Camel flu
| image = MERS-CoV electron micrograph3.jpg
| alt =
| caption = MERS-CoV virions
| field = [[Infectious disease (medical specialty)|Infectious disease]]
| symptoms = Fever, cough, [[shortness of breath]]<ref name=WHO2019/>
| complications =
| onset = 2 to 14 days post exposure<ref name=CDC2020Pro/>
| duration = 2012–present2012–2020<ref name=MERSUpdateMar2021/>
| types =
| causes = [[Middle East respiratory syndrome-related coronavirus|MERS-coronavirus]] (MERS-CoV)<ref name=WHO2019/>
| risks = Contact with [[camels]] and camel products<ref name=WHO2019/>
| diagnosis = [[Reverse transcription polymerase chain reaction|rRT-PCR testing]]<ref name=CDC2020Diag/>
| differential =
| prevention = Hand washing, avoiding contact with camels and camel products<ref name=NHS2018>{{cite web |title=Middle East respiratory syndrome (MERS) |url=https://www.nhs.uk/conditions/middle-east-respiratory-syndrome-mers/ |website=nhs.uk |access-date=15 April 2020 |language=en |date=23 August 2018 |archive-date=12 April 2020 |archive-url=https://web.archive.org/web/20200412204450/https://www.nhs.uk/conditions/middle-east-respiratory-syndrome-mers/ |url-status=live }}</ref>
| treatment = [[Symptomatic treatment|Symptomatic]] and [[supportive treatment|supportive]]<ref name=WHO2019/>
| medication =
| prognosis = 34.4% risk of death (all countries)
| frequency = 2578 cases (as of October 2021)<ref name=MERSUpdateMar2021/>
| deaths = 888<ref name=MERSUpdateMar2021/>
}}
<!-- Definition and symptoms -->
'''Middle East respiratory syndrome''' ('''MERS''') is a viral [[respiratory infection]] caused by ''[[Middle East respiratory syndrome–related coronavirus]]'' (MERS-CoV).<ref name=WHO2019/> Symptoms may range from none, to mild, to severe depending on age and risk level .<ref name=Lancet2015/><ref name=WHO2019/> Typical symptoms include [[fever]], [[cough]], [[diarrhea]], and [[shortness of breath]].<ref name=WHO2019/> The disease is typically more severe in those with other health problems.<ref name=WHO2019/><ref name=Lancet2015>{{cite journal | vauthors = Zumla A, Hui DS, Perlman S | title = Middle East respiratory syndrome | journal = Lancet | volume = 386 | issue = 9997 | pages = 995–1007 | date = September 2015 | pmid = 26049252 | pmc = 4721578 | doi = 10.1016/S0140-6736(15)60454-8 }}</ref>
 
<!-- Epidemiology and history -->
Line 33 ⟶ 34:
 
<!-- Cause and diagnosis -->
MERS-CoV is a virus in the [[coronavirus]] family believed to be originally from bats.<ref name=WHO2019/> However, humans are typically infected from [[camels]], either during direct contact or indirectly through respiratory droplets.<ref name=WHO2019/> [[Human-to-human transmission|Spread between humans]] typically requires close contact with an infected person.<ref name=WHO2019/> Its spread is uncommon outside of hospitals.<ref name=Lancet2015/> Thus, its risk to the global population is currently deemed to be Significantlysignificantly low.<ref name=Lancet2015/> Diagnosis is by [[Reverse transcription polymerase chain reaction|rRT-PCR testing]] of blood and respiratory samples.<ref name=CDC2020Diag>{{cite web |title=MERS-CoV {{!}} Interim Guidelines for Clinical Specimens from PUI {{!}} CDC |url=https://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html |website=www.cdc.gov |access-date=16 April 2020 |language=en-us |date=23 March 2020 |archive-date=13 April 2020 |archive-url=https://web.archive.org/web/20200413110437/https://www.cdc.gov/coronavirus/mers/guidelines-clinical-specimens.html |url-status=live }}</ref>
 
<!-- Prevention and treatment -->
Line 57 ⟶ 58:
 
==== Camels ====
A study performed between 2010 and 2013, in which the incidence of MERS was evaluated in 310 [[dromedary|dromedary camels]], revealed high titers of neutralizing antibodies to MERS-CoV in the blood serum of these animals.<ref name=Hemida12dec2013/> A further study sequenced MERS-CoV from nasal swabs of [[dromedary]] camels in Saudi Arabia and found they had sequences identical to previously sequenced human isolates. Some individual camels were also found to have more than one genomic variant in their [[Pharynx|nasopharynx]].<ref name=Briese29apr2014/> There is also a 2014 report of a Saudi Arabian man who became ill seven days after applying topical medicine to the noses of several sick camels and later he and one of the camels were found to have identical strains of MERS-CoV.<ref name=BBC5jun2014/><ref name=Azhar4jun2014/> It is still unclear how the virus is transmitted from camels to humans. In 2014, the Saudi Ministry of Agriculture advised people to avoid contact with camels or wear breathing masks when around them.<ref name=BBC11may2014/> In response "some people have refused to listen to the government's advice"<ref name=BBC13may2014/> and kiss their camels in defiance of their government's advice. In 2020, the World Health Organization advised avoiding contact with camels and to eat only fully cooked camel meat, pasteurized camel milk, and to avoid drinking [[camel urine]].<ref>{{Cite web|url=https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)|title=Middle East respiratory syndrome coronavirus (MERS-CoV)|website=www.who.int|language=en|access-date=6 April 2020-04-06|archive-date=2 April 2020|archive-url=https://web.archive.org/web/20200402002412/https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)|url-status=live}}</ref>
 
==== Between people ====
Line 109 ⟶ 110:
The duration of infectivity is also unknown so it is unclear how long people must be isolated, but current recommendations are for 24 hours after resolution of symptoms. In the SARS outbreak the virus was not cultured from people after the resolution of their symptoms.<ref name=Chan2004feb/>
 
It is believed that the existing [[SARS]] research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.<ref name=Jiang2013/><ref name=Butler3oct2013/> As of March 2020 there was one ([[DNA vaccination|DNA based]]) MERS vaccine which completed [[Phases of clinical research|phase I clinical trials]] in humans,<ref>{{cite journal|title=Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.|year=2019|pmid=31351922|doi=10.1016/S1473-3099(19)30266-X|last1=Modjarrad|first1=Kayvon|last2=Roberts|first2=Christine C.|last3=Mills|first3=Kristin T.|last4=Castellano|first4=Amy R.|last5=Paolino|first5=Kristopher|last6=Muthumani|first6=Kar|last7=Reuschel|first7=Emma L.|last8=Robb|first8=Merlin L.|last9=Racine|first9=Trina|last10=Oh|first10=Myoung-don|last11=Lamarre|first11=Claude|last12=Zaidi|first12=Faraz I.|last13=Boyer|first13=Jean|last14=Kudchodkar|first14=Sagar B.|last15=Jeong|first15=Moonsup|last16=Darden|first16=Janice M.|last17=Park|first17=Young K.|last18=Scott|first18=Paul T.|last19=Remigio|first19=Celine|last20=Parikh|first20=Ajay P.|last21=Wise|first21=Megan C.|last22=Patel|first22=Ami|last23=Duperret|first23=Elizabeth K.|last24=Kim|first24=Kevin Y.|last25=Choi|first25=Hyeree|last26=White|first26=Scott|last27=Bagarazzi|first27=Mark|last28=May|first28=Jeanine M.|last29=Kane|first29=Deborah|last30=Lee|first30=Hyojin|journal=The Lancet Infectious Diseases|volume=19|issue=9|pages=1013–1022|pmc=7185789|display-authors=29|doi-access=free}}</ref> and three others in progress all of which are viral vectored vaccines, two [[Adenoviridae#Use in gene therapy and vaccination|adenoviral vectored]] ([[ChAdOx1]]-MERS,<ref>{{cite web| url=https://clinicaltrials.gov/ct2/show/NCT03399578| title=Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)| access-date=18 March 2020| archive-date=18 March 2020| archive-url=https://web.archive.org/web/20200318220542/https://clinicaltrials.gov/ct2/show/NCT03399578| url-status=live}}</ref><ref>{{cite web| url=https://clinicaltrials.gov/ct2/show/NCT04170829| title=Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS002)| access-date=18 March 2020| archive-date=18 March 2020| archive-url=https://web.archive.org/web/20200318220536/https://clinicaltrials.gov/ct2/show/NCT04170829| url-status=live}}</ref> BVRS-GamVac<ref>{{cite web| url=https://clinicaltrials.gov/ct2/show/NCT04130594| title=Study of Safety and Immunogenicity of BVRS-GamVac| access-date=18 March 2020| archive-date=18 March 2020| archive-url=https://web.archive.org/web/20200318220529/https://clinicaltrials.gov/ct2/show/NCT04130594| url-status=live}}</ref>) and one [[Modified vaccinia Ankara|MVA]] vectored (MVA-MERS-S<ref>{{cite web| url=https://clinicaltrials.gov/ct2/show/NCT03615911| title=Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S| access-date=18 March 2020| archive-date=17 March 2020| archive-url=https://web.archive.org/web/20200317170621/https://clinicaltrials.gov/ct2/show/NCT03615911| url-status=live}}</ref>).<ref>{{cite journal|title=Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus|year=2019|pmid=31428074|doi=10.3389/fmicb.2019.01781|last1=Yong|first1=Chean Yeah|last2=Ong|first2=Hui Kian|last3=Yeap|first3=Swee Keong|last4=Ho|first4=Kok Lian|last5=Tan|first5=Wen Siang|journal=Frontiers in Microbiology|volume=10|pages=1781|pmc=6688523|doi-access=free}}</ref>
 
== Treatment ==
Line 139 ⟶ 140:
| 44%
|-
| align="left" | [[South Korea]]<ref>{{cite news | url=https://news.chosun.com/site/data/html_dir/2015/11/25/2015112500517.html | title=Last MERS patient died | publisher=chosun.com | date=25 NovNovember 2015 | access-date=4 February 2020 | archive-date=4 February 2020 | archive-url=https://web.archive.org/web/20200204153322/https://news.chosun.com/site/data/html_dir/2015/11/25/2015112500517.html | url-status=live }}</ref>
| 184
| 38
Line 199 ⟶ 200:
| 50%
|-
| align="left" | [[Spain]]<ref>{{cite web | url=https://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_20_Jan_2014.pdf | title=Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update–as of 20 January 2014 | publisher=[[World Health Organization]] | date=20 January 2014 | access-date=13 May 2014 | type=PDF | archive-date=29 April 2014 | archive-url=https://web.archive.org/web/20140429094050/http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_Update_20_Jan_2014.pdf | url-status=live }}</ref><ref>{{cite web | url=http://www.cidrap.umn.edu/news-perspective/2014/01/who-2-probable-mers-cases-spain-never-confirmed | title=US detects 2nd MERS case; Saudi Arabia has 18 more | publisher=[[Center for Infectious Disease Research and Policy]] | date=21 January 2014 | access-date=13 May 2014 | first1=Lisa | last1=Schnirring | name-list-style=vanc | archive-date=19 February 2014 | archive-url=https://web.archive.org/web/20140219091013/http://www.cidrap.umn.edu/news-perspective/2014/01/who-2-probable-mers-cases-spain-never-confirmed | url-status=live }}</ref>
| 2
| 0
Line 284 ⟶ 285:
MERS was also implicated in an outbreak in April 2014 in [[Saudi Arabia]], where MERS has infected 688 people and 282 MERS-related deaths have been reported since 2012.<ref name=NYT20140604/> In response to newly reported cases and deaths, and the resignation of four doctors at Jeddah's King Fahd Hospital who refused to treat MERS patients for fear of infection, the government removed the Minister of Health and set up three MERS treatment centers.<ref name=KhaleejTimes27apr2014/><ref name=Reuters27apr2014/> Eighteen more cases were reported in early May.<ref name=Reuters08may2014/> In June 2014, Saudi Arabia announced 113 previously unreported cases of MERS, revising the death toll to 282.{{citation needed|date=June 2022}}
 
A hospital-related outbreak in Riyadh in the summer of 2015 increased fears of an epidemic occurring during the annual [[Hajj]] pilgrimage that was to begin in late September. After a period of few cases, cases began increasing in the middle of the summer.<ref>{{cite magazine|last1=McKenna|first1=Maryn|title=MERS Cases Increasing in Saudi Arabia, And The Hajj Is Coming|url=http://phenomena.nationalgeographic.com/2015/08/22/mers-saudi-1/|magazine=National Geographic|access-date=23 August 2015|archive-date=23 August 2015|archive-url=https://web.archive.org/web/20150823140819/http://phenomena.nationalgeographic.com/2015/08/22/mers-saudi-1/|url-status=livedead}}</ref> The [[Centers for Disease Control and Prevention|CDC]] placed the travel health alert to level 2, which calls for taking enhanced precautions.<ref>{{cite web|title=Hajj and Umrah in Saudi Arabia|url=http://wwwnc.cdc.gov/travel/notices/alert/hajj-umrah-saudi-arabia-2015|publisher=Centers for Disease Control and Prevention|access-date=23 August 2015|archive-date=10 August 2015|archive-url=https://web.archive.org/web/20150810085910/http://wwwnc.cdc.gov/travel/notices/alert/hajj-umrah-saudi-arabia-2015|url-status=live}}</ref>
 
In May 2019, 14 cases of MERS were reported to the World Health OrganisationOrganization (WHO) by Saudi authorities, of which five were fatal. All those who died had comorbidities and other relatively serious health problems ranging from only [[diabetes mellitus]] in one person (aged 35) to complicated combinations of diabetes mellitus, [[hypertension]] and [[ischemic heart disease]] in two (65 and 80 years old) and diabetes mellitus, hypertension and nephropathy in another one who was 73 years old. Another patient who died and was 64 years old, had diabetes mellitus and hypertension. All those who died were males and three of them were reported to have had contact with, and exposure to, camels. Among the nine persons who survived were two females who were believed to have had contact with a person infected with MERS, one being a 23-year-old healthcare worker. Of the total 14 cases, four were females and 10 were males. All females survived. Reports of fatal cases were from Riyadh, Jeddah, Madinah and Najran. WHO did not recommend screening of travelers upon arrival or traveling restrictions.<ref>[https://web.archive.org/web/20190719183129/https://www.who.int/csr/don/16-july-2019-mers-saudi-arabia/en/ Middle East respiratory syndrome coronavirus (MERS-CoV) – The Kingdom of Saudi Arabia] ''World Health Organisation (WHO)'' '''(Official website)''' Organization
[https://web.archive.org/web/20190719183129/https://www.who.int/csr/don/16-july-2019-mers-saudi-arabia/en/ Archived Edition (Permanent Link)]. Retrieved and archived on 19 July 2019</ref><ref>[https://www.who.int/csr/don/20190626_mers_saudi_arabia.xls?ua=1 Excel spreadsheet: 20190626_mers_saudi_arabia.xls] ''World Health Organisation (WHO)'' '''(Official website)''' Organization
[https://web.archive.org/web/20190719183141/https://www.who.int/csr/don/20190626_mers_saudi_arabia.xls?ua=1 Archived Edition (Permanent Link)] Retrieved and archived on 19 July 2019</ref>
 
===United States===
Line 299 ⟶ 302:
In May 2015, the first case in South Korea was confirmed in a man who had visited Saudi Arabia, United Arab Emirates and Bahrain.<ref name=USAToday2jun2015/> Another man from South Korea, who was travelling to China, was diagnosed as the first case in China. So far, no Chinese citizen has been found infected.<ref name=Xinhua30may2015/>
 
As of 27 June 2015, 19 people in South Korea have died from [[2015 Middle East respiratory syndrome coronavirus outbreak in South Korea|this outbreak]], with 184 confirmed cases of infection.<ref>{{cite news | url=http://koreajoongangdaily.joins.com/news/article/article.aspx?aid=3005306 | title=MERS forces total sealing off of two hospitals | date=12 June 2015 | access-date=11 June 2015 | archive-date=12 June 2015 | archive-url=https://web.archive.org/web/20150612031621/http://koreajoongangdaily.joins.com/news/article/Article.aspx?aid=3005306 | url-status=live }}</ref> There have been at least 6508 quarantined.<ref>{{cite news | url=https://www.reuters.com/article/health-mers-southkorea-idUSL3N0YU5TT20150609 | title=REFILE-UPDATE 2-Hong Kong to issue "red travel alert" to South Korea as MERS spreads | work=Reuters | first1=Ju-min | last1=Park | first2=James | last2=Pomfret | name-list-style=vanc | date=8 June 2015 | access-date=5 July 2021 | archive-date=23 August 2021 | archive-url=https://web.archive.org/web/20210823222950/https://www.reuters.com/article/health-mers-southkorea-idUSL3N0YU5TT20150609 | url-status=live }} (Article published in Eastern Daylight Time)</ref><ref name=wsj4june/><ref name=Today8Jun2015/><ref name=ID7Jun2015/><ref name=KoreaMW8Jun2015/><ref name=NetEase7Jun2015/>{{citation overkill|date=November 2020}}
 
In 2018 a case was found in South Korea; the patient had recently returned from Kuwait (via Dubai).<ref>{{cite news|title=South Korea searching for 50 foreigners possibly exposed to Mers|url=https://www.straitstimes.com/asia/east-asia/south-korea-searching-for-50-foreigners-possibly-exposed-to-mers|date=11 September 2018|access-date=24 January 2020|newspaper=The Straits Times|archive-date=13 September 2018|archive-url=https://web.archive.org/web/20180913040833/https://www.straitstimes.com/asia/east-asia/south-korea-searching-for-50-foreigners-possibly-exposed-to-mers|url-status=live}}</ref>
Line 307 ⟶ 310:
===Philippines===
In April 2014, MERS emerged in the [[Philippines]] with a suspected case of a home-bound Overseas Filipino Worker (OFW). Several suspected cases involving individuals who were on the same flight as the initial suspected case are being tracked but are believed to have dispersed throughout the country. Another suspected MERS-involved death in [[Sultan Kudarat]] province caused the Department of Health (DOH) to put out an alert.<ref name=GMA24apr2014a/><ref name=GMA24apr2014b/><ref name=MindaNews22apr2014/><ref name=PhilStar18sep2013/>
On 6 July 2015 the [[Department of Health|DOH]] confirmed the second case of MERS in the Philippines. A 36-year-old male foreigner from the Middle East was tested positive.<ref>{{cite news | url=http://cnnphilippines.com/news/2015/07/06/merscov-philippines-doh.html | title=DOH confirms MERS case in PH | date=6 July 2015 | access-date=8 July 2015 | archive-date=6 July 2015 | archive-url=https://web.archive.org/web/20150706090646/http://cnnphilippines.com/news/2015/07/06/merscov-philippines-doh.html | url-status=livedead }}</ref>
 
===United Kingdom===
On 27 July 2015, the accident and emergency department at [[Manchester Royal Infirmary]] closed after two patients were treated for suspected MERS infection.<ref>{{cite news|url=https://www.bbc.co.uk/news/uk-england-manchester-33675356|title=Manchester Royal Infirmary A&E unit closed over virus outbreak|date=27 July 2015|work=BBC News|access-date=27 July 2015|archive-date=27 July 2015|archive-url=https://web.archive.org/web/20150727165051/http://www.bbc.co.uk/news/uk-england-manchester-33675356|url-status=live}}</ref> The facility was reopened later that evening, and it was later confirmed by [[Public Health England]] that the two patients had tested negative for the disease.<ref>{{cite web|url=http://www.manchestereveningnews.co.uk/news/greater-manchester-news/two-patients-manchester-test-negative-9741801|title=Two patients in Manchester test negative for MERS virus|first1=Amy|last1=Glendinning|name-list-style=vanc|date=28 July 2015|website=men|access-date=28 July 2015|archive-date=22 August 2015|archive-url=https://web.archive.org/web/20150822204902/http://www.manchestereveningnews.co.uk/news/greater-manchester-news/two-patients-manchester-test-negative-9741801|url-status=live}}</ref>
 
===Kenya===
Line 393 ⟶ 396:
<ref name=CDC10apr2015>{{cite web|url=https://www.cdc.gov/coronavirus/mers/case-def.html |title=Middle East Respiratory Syndrome (MERS): Case definitions |date=10 April 2015 |access-date=2 June 2015 |publisher=[[Centers for Disease Control and Prevention|CDC]] |url-status=dead |archive-url=https://web.archive.org/web/20140527094632/http://www.cdc.gov/coronavirus/mers/case-def.html |archive-date=27 May 2014 }}</ref>
 
<ref name=HPA14mar2013>{{cite journal | title = State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans | journal = PLOS Currents | volume = 5 | date = November 2013 | pmid = 24270606 | pmc = 3828229 | doi = 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8 | last1 = The Who Mers-Cov Research Group | doi-broken-date = 5 April 2024 | doi-access = free }} {{open access}}</ref>
 
<ref name=WHOsep2013>{{cite web | url = https://www.who.int/csr/disease/coronavirus_infections/MERS_Lab_recos_16_Sept_2013.pdf?ua=1 | title = Laboratory Testing for Middle East Respiratory Syndrome Coronavirus | date = September 2013 | access-date = 19 May 2014 | publisher = [[World Health Organization|WHO]] | archive-date = 14 May 2014 | archive-url = https://web.archive.org/web/20140514204048/http://www.who.int/csr/disease/coronavirus_infections/MERS_Lab_recos_16_Sept_2013.pdf?ua=1 | url-status = live }}</ref>
 
<ref name=Corman27sep2012>{{cite journal | vauthors = Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, Muth D, Müller MA, Drexler JF, Zambon M, Osterhaus AD, Fouchier RM, Drosten C | title = Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction | journal = Euro Surveillance | volume = 17 | issue = 39 | date = September 2012 | pmid = 23041020 | doi=10.2807/ese.17.39.20285-en| doi-access = free | hdl = 1765/87211 | hdl-access = free }} {{open access}}</ref>
 
<ref name=Corman6dec2012>{{cite journal | vauthors = Corman VM, Müller MA, Costabel U, Timm J, Binger T, Meyer B, Kreher P, Lattwein E, Eschbach-Bludau M, Nitsche A, Bleicker T, Landt O, Schweiger B, Drexler JF, Osterhaus AD, Haagmans BL, Dittmer U, Bonin F, Wolff T, Drosten C | title = Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections | journal = Euro Surveillance | volume = 17 | issue = 49 | date = December 2012 | pmid = 23231891 | doi=10.2807/ese.17.49.20334-en | doi-access = free | hdl = 1765/91517 | hdl-access = free }} {{open access}}</ref>
 
<ref name=Lu1jan2014>{{cite journal | vauthors = Lu X, Whitaker B, Sakthivel SK, Kamili S, Rose LE, Lowe L, Mohareb E, Elassal EM, Al-sanouri T, Haddadin A, Erdman DD | title = Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus | journal = Journal of Clinical Microbiology | volume = 52 | issue = 1 | pages = 67–75 | date = January 2014 | pmid = 24153118 | pmc = 3911421 | doi = 10.1128/JCM.02533-13 }}</ref>
 
<ref name=Reusken4apr2013>{{cite journal | vauthors = Reusken C, Mou H, Godeke GJ, van der Hoek L, Meyer B, Müller MA, Haagmans B, de Sousa R, Schuurman N, Dittmer U, Rottier P, Osterhaus A, Drosten C, Bosch BJ, Koopmans M | title = Specific serology for emerging human coronaviruses by protein microarray | journal = Euro Surveillance | volume = 18 | issue = 14 | pages = 20441 | date = April 2013 | pmid = 23594517 | doi = 10.2807/1560-7917.es2013.18.14.20441 | doi-access = free | hdl = 1765/87235 | hdl-access = free }}</ref>
 
<ref name=Falzarano8sep2013>{{cite journal | vauthors = Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D, Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann H | title = Treatment with interferon-αあるふぁ2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques | journal = Nature Medicine | volume = 19 | issue = 10 | pages = 1313–7 | date = October 2013 | pmid = 24013700 | pmc = 4093902 | doi = 10.1038/nm.3362 }}</ref>
Line 433 ⟶ 436:
<ref name=Chan2004feb>{{cite journal | vauthors = Chan KH, Poon LL, Cheng VC, Guan Y, Hung IF, Kong J, Yam LY, Seto WH, Yuen KY, Peiris JS | title = Detection of SARS coronavirus in patients with suspected SARS | journal = Emerging Infectious Diseases | volume = 10 | issue = 2 | pages = 294–9 | date = February 2004 | pmid = 15030700 | pmc = 3322905 | doi = 10.3201/eid1002.030610 }}</ref>
 
<ref name=Jiang2013>{{cite news | title=Development of SARS Vaccines and Therapeutics Is Still Needed | url=http://www.medscape.com/viewarticle/777375 | first1=Shibo | last1=Jiang | first2=Lu | last2=Lu | first3=Lanying | last3=Du | name-list-style=vanc | year=2013 | access-date=29 May 2013 | work=[[Medscape]] | archive-date=18 March 2013 | archive-url=https://web.archive.org/web/20130318210712/http://www.medscape.com/viewarticle/777375 | url-status=live }}</ref>
 
<ref name=Butler3oct2013>{{cite journal | vauthors = Butler D | title = SARS veterans tackle coronavirus | journal = Nature | volume = 490 | issue = 7418 | pages = 20 | date = October 2012 | pmid = 23038444 | doi = 10.1038/490020a | bibcode = 2012Natur.490...20B | doi-access = free }}</ref>